Infectious diseases still remain the most serious threat to public health and the leading cause of death worldwide despite remarkable advances in modern medicine. Antimicrobial agents, once considered as "miracle drugs" to cure patients with infectious diseases, have been losing their power due to widespread emergence of antimicrobial resistance. Given the global emergence of antimicrobial resistance and newly emerging infectious diseases such as SARS or avian influenza, international collaboration is critical for effective control and prevention of infectious diseases.
The Asia Pacific Foundation for Infectious Diseases (APFID), Asia's first international foundation specifically for infectious diseases, was founded to improve the global health through Asian initiatives by strengthening and coordinating national and international research-related activities on infectious diseases and antimicrobial resistance.
APFID is supporting the international research activities of the 'Asian Network for Surveillance of Resistant Pathogens (ANSORP)' as well as basic research by the 'Asian Bacterial Bank (ABB)' and the 'Infectious Disease Research Institute (IDRI)'. APFID is also organizing the 'International Symposium on Antimicrobial Agents and Resistance (ISAAR)' to exchange the scientific information on infectious diseases and antimicrobial resistance in the Asia-Pacific region. I CARE (Initiatives to Control Antimicrobial Resistance) is an international campaign program to control and prevent antimicrobial resistance in the Asia-Pacific region. All these systems of APFID are effectively integrated to achieve its mission and future vision of the foundation.
Through active collaboration and partnership with institutions, organizations, industries, and academic societies, I wish APFID contribute to improvement of public health in the Asia-Pacific region.
Thank you very much.
Founder & Chairman, APFID
Professor of Medicine, Samsung Medical Center
Sungkyunkwan University Seoul, Korea